Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» GSK
GSK
Malaria Vaccine 30 Years And $1 Billion In The Making Now Deployed In Third Country
Forbes
Tue, 09/24/19 - 07:12 pm
Africa
malaria
vaccines
GSK
Gates Foundation
Malawi
Ghana
Kenya
The Week Ahead In Biotech: Spotlight On ESMO Conference
Yahoo/Benzinga
Sun, 09/22/19 - 11:10 pm
JNJ
daratumumab
Urogen
Rhythm Pharmaceuticals
Anavex
Aravive Biologics
TrovaGene
Incyte
AstraZeneca
Roche
Amgen
Aslan
G1 Therapeutics
GSK
Calithera Biosciences
Seattle Genetics
Immunomedics
Checkpoint Therapeutics
Aileron Therapeutics
Genocea Biosciences
AbbVie
Zymeworks
HIV vaccine shows signs of cross-subtype protection
Fierce Biotech
Fri, 09/20/19 - 09:44 am
vaccines
HIV
ALVAC‐HIV
Sanofi Pasteur
GSK
JNJ
South Africa
clinical trials
Microsoft nominates GSK CEO Walmsley to board
Yahoo/Reuters
Fri, 09/20/19 - 09:14 am
Microsoft
GSK
Pharma CEOs
Emma Walmsley
GSK's oral nicotine spray wins divided FDA panel's backing despite abuse risks
Fierce Pharma
Thu, 09/19/19 - 12:35 pm
GSK
FDA
advisory panels
OTC
Glaxo's Asthma Drug Nucala Gets FDA Nod for Pediatric Use
Yahoo/Zacks.com
Fri, 09/13/19 - 10:59 am
GSK
Nucala
eosinophilic asthma
pediatrics
FDA
Who joins Purdue on pharma's top settlements list? Merck, GSK and Pfizer, for starters
Fierce Pharma
Thu, 09/12/19 - 12:01 pm
Purdue Pharma
legal
Merck
GSK
Pfizer
Drug companies pay for exclusive access to UK genetic data
Biopharma Dive
Thu, 09/12/19 - 11:35 am
UK
genetic database
Amgen
AstraZeneca
JNJ
GSK
'I'm quite frankly baffled': Teva's $235M overturn in GSK patent case has judge 'bewildered'
Fierce Pharma
Fri, 09/6/19 - 12:37 pm
Teva Pharmaceutical
GSK
Coreg
patents
ESMO 2019 preview – PARPs on parade
EP Vantage
Thu, 09/5/19 - 12:06 pm
ESMO
PARP inhibitors
Lynparza
AstraZeneca
ovarian cancer
GSK
Zejula
GSK licenses Ionis' midphase hepatitis B program for $25M
Fierce Biotech
Tue, 08/27/19 - 09:51 am
GSK
Ionis Pharmaceuticals
antisense
hepatitis B
GSK's anti-BCMA drug hits goal in pivotal multiple myeloma test
Fierce Biotech
Fri, 08/23/19 - 10:14 am
GSK
anti-BCMA
Multiple Myeloma
belantamab mafodotin
GSK's ViiV reports positive data for long-acting two-drug HIV therapy
Biopharma Dive
Thu, 08/22/19 - 11:46 am
ViiV Healthcare
GSK
HIV
cabotegravir
rilpivirine
Chasing Astellas and Mitsubishi, GSK files for Japanese approval of oral anemia drug
Fierce Biotech
Wed, 08/21/19 - 09:33 am
GSK
Japan
renal anemia
daprodustat
GSK appeals to parents with latest meningitis B commercial
Fierce Pharma
Mon, 08/12/19 - 11:03 am
GSK
meningitis B
vaccines
drug ads
Shifting focus to oncology, GSK recruits a cancer vet as new chief of US pharmaceuticals — adding another woman to the top ranks of biopharma
Endpoints
Mon, 08/12/19 - 10:49 am
GSK
oncology
Merck KGaA
Maya Martinez-Davis
GSK offloads Ebola vaccines as testing of J&J shot ramps up
Fierce Biotech
Tue, 08/6/19 - 10:56 am
GSK
ebola virus
JNJ
vaccines
Sabin Vaccine Institute
GSK split edges closer as OTC joint venture deal with Pfizer closes
Pharmaforum
Thu, 08/1/19 - 11:48 am
GSK
Pfizer
OTC
M&A
Drugmakers will profit from climate change, Morgan Stanley says
Beckers Hospital Review
Sun, 07/28/19 - 11:41 pm
climate change
Morgan Stanley
Merck
Sanofi
vaccines
GSK
Takeda
JNJ
Moderna Therapeutics
With pharma-consumer split in its sights, GSK hands chairman seat to Symonds
Fierce Pharma
Wed, 07/24/19 - 09:56 pm
GSK
Jonathan Symonds
Pages
« first
‹ previous
…
32
33
34
35
36
37
38
39
40
…
next ›
last »